SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001583648-18-000026
Filing Date
2018-04-26
Accepted
2018-04-26 07:49:44
Documents
6
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q/A pirs-form10xq_a.htm 10-Q/A 44212
2 EXHIBIT 10.1 ex101.htm EX-10.1 1153056
3 EXHIBIT 10.2 ex102.htm EX-10.2 225358
4 EXHIBIT 10.4 ex104.htm EX-10.4 26336
5 EXHIBIT 31.1 ex311.htm EX-31.1 6182
6 EXHIBIT 31.2 ex312.htm EX-31.2 6062
  Complete submission text file 0001583648-18-000026.txt   1462334
Mailing Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109
Business Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109 857-246-8998
PIERIS PHARMACEUTICALS, INC. (Filer) CIK: 0001583648 (see all company filings)

IRS No.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-37471 | Film No.: 18776195
SIC: 8731 Services-Commercial Physical & Biological Research